Chen, Shilin
Hu, Weigang
Wang, Jiazhou
Xu, Yao
Funding for this research was provided by:
National Natural Science Foundation of China (12375339)
National Natural Science Foundation of China (12475339)
Article History
Received: 14 July 2025
Accepted: 21 November 2025
First Online: 6 December 2025
Declarations
:
: The study was approved by the Clinical Research Ethics Committee of Fudan University Shanghai Cancer Center. All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and the principles of the Declaration of Helsinki. Informed consent for research participation and publication, as part of the general consent for treatment, was obtained from all individual participants included in the study.
: Not applicable.
: The authors declare no competing interests.